You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE

Article metrics

Article menu
Clinical trials and drug discovery
Original research
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE

 

Online download statistics by month:

Online download statistics by month: July 2022 to March 2024

AbstractFullPdf
Jul 2022717720150
Aug 202233233585
Sep 202220821682
Oct 202214915057
Nov 202214114261
Dec 202211711639
Jan 202310510438
Feb 2023817629
Mar 20231049441
Apr 202314814745
May 202312511439
Jun 202312812129
Jul 202312011031
Aug 2023969040
Sep 2023827627
Oct 2023646231
Nov 2023716926
Dec 2023757429
Jan 2024605630
Feb 2024807632
Mar 20248172100
Total308430201041